US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% NVDA $216.00 ▲+2.39% META $630.56 ▼-1.88% SPCX $146.90 ▼-0.40% AAPL $343.91 ▼-1.10% MSFT $532.60 ▲+1.54% INTC $90.47 ▲+4.04%
FinancialContent

RxSight, Inc. - Common Stock (NQ:RXST)

4.930 -0.090 (-1.79%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter ↗
 
Via Benzinga
News headline image
RxSight, Inc. Reports First Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
From RxSight, Inc.
Via GlobeNewswire
News headline image
Expert Outlook: RxSight Through The Eyes Of 11 Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) ↗
 
Via Benzinga
News headline image
What's going on in today's session ↗
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations ↗
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead. 
Via Benzinga
News headline image
Forecasting The Future: 4 Analyst Projections For RxSight ↗
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
11 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Thursday. ↗
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall ↗
 
Via Benzinga
Topics Stocks
News headline image
RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges ↗
RxSight shares down premarket on revised FY25 outlook. CEO cites headwinds in premium IOL market and economy. 
Via Benzinga
News headline image
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
The Analyst Verdict: RxSight In The Eyes Of 9 Experts ↗
 
Via Benzinga
News headline image
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >